Wall Street drifted through a mixed day of trading as rising fashion and cigarette stocks worked against drops for Ford Motor ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

U.S. stock futures are edging mostly higher as investors watch corporate earnings, Honeywell plans to split into three companies, and Qualcomm stock drops as its licensing revenue misses expectations.

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Cabarrus is generally a pretty affluent and prosperous county, especially compared with many of the other counties across North Carolina ... to the area. Eli Lilly, which first broke ground ...

In the latest episode of the Bring It Home podcast, Geoffrey Bailey spoke about his work in organizing logistics for gathering and transporting mineral components to product manufacturers in the U.S.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion.

Winter sports in Western North Carolina are in Week 10 of the season ... Cagle won the 138-pound class at the Mountain 7 ...